Market Signal Briefing

A handful of stocks benefited massively during the pandemic. It was an interesting time to be an investor, to say the least, and those who targeted the stay-at-home stocks were rewarded handsomely with considerable gains.

A few of those stocks include Shopify (SHOP - Free Report) and Zoom Video Communications (ZM - Free Report) . Let’s take a closer look at each.

Shopify Stands TallShopify’s platform gained widespread attention during the period as consumers increasingly shifted to online shopping. To little surprise, the digital trend has continued to only get more popular, providing the company with serious growth since.  

And its earnings results have helped reinforce the idea, which have regularly been strong over recent periods. Sales grew 31% year-over-year throughout its latest period, with SHOP posting double-digit percentage YoY sales growth in ten consecutive periods.

Importantly, the EPS outlook for its current fiscal year remains one of positivity, with the current $1.07 Zacks Consensus EPS estimate for its current fiscal year up 16% over the last year.

Image Source: Zacks Investment Research

Zoom Sees Weak SalesZoom Video Communications’ cloud-native unified communications platform combines video, audio, phone, screen sharing, and chat functionalities. It’s easy to understand why shares gained popularity during that period, as many were forced onto the platform for both personal professional reasons.

Sales exploded during the pandemic before leveling off significantly over recent years, as shown below.

Image Source: Zacks Investment Research

ZM’s sales grew by nearly 5% from the year-ago period in its latest release, with adjusted EPS of $1.53 climbing 10% year-over-year. Its cash-generating abilities did see a nice boost, with operating cash flow of $516 million up from the $449.3 million mark in the same period last year. Free cash flow of $508 million was up big from $365 million in the year-ago quarter.

EPS expectations for its current fiscal year do reflect positivity, with the current $3.60 Zacks Consensus EPS estimate up nearly 40% over the last year.

Image Source: Zacks Investment Research

Bottom Line

While stocks such as Shopify (SHOP - Free Report) and Zoom Video Communications (ZM - Free Report) were widely hailed during the pandemic, the attention since has drastically reduced.  

Shopify has, and remains, the true leader of the group concerning overall performance and fundamentals. The company hasn’t struggled post-pandemic like others, with the staying power of online shopping driving the positivity. 

Zoom shares have shown life off lows, though shares remain in desperate need of a strong quarterly release that reveals meaningful sales growth.

MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (TSXV: MDX), (“MedX” or the “Company”), a global leader in teledermatology and non-invasive skin analysis, today announced the appointment of Dr. Symon D. Cotton, accomplished medical device innovator and co-developer of SIAscopy®, as Strategic Advisor to the Company.

Dr. Cotton is an experienced author and leader in medical technology innovation, currently serving as Head of Life Sciences at a leading technology organization. His career has been defined by work at the intersection of engineering, biology and computation, where he has successfully guided numerous companies through the development of novel medical devices and digital health platforms.

As one of the key scientific architects of Spectrophotometric Intracutaneous Analysis (SIAscopy®), Dr. Cotton collaborated with Dr. Paul Matts in its early development and codification. Together, they helped establish SIAscopy as the world’s first technology to enable the simultaneous, non-invasive measurement of melanin, hemoglobin and collagen within the skin. Their work provided the foundation for SIAscopy’s clinical adoption in dermatology and its integration into MedX’s DermSecure® platform.

Beyond his foundational contributions, Dr. Cotton’s expertise extends to applying AI-driven analytics to medical imaging and diagnostics, a skill set directly aligned with MedX’s strategic roadmap. His leadership in computational biology, device design, and translational medicine equips MedX to further enhance its AI models trained on SIAscopy’s uniquely rich imaging datasets, driving greater diagnostic accuracy and scalability.

“I am proud to have been part of the original SIAscopy journey and excited to rejoin the field with MedX at such a pivotal moment,” said Dr. Cotton. “With AI poised to transform teledermatology, I look forward to helping MedX leverage its unmatched imaging database and DermSecure® platform to improve early skin cancer detection worldwide.”

John Gevisser, CEO of MedX Health, added: “Dr. Cotton’s contribution to SIAscopy was instrumental in shaping the technology that underpins MedX’s global teledermatology platform today. His expertise in medical device innovation and computational and AI strategy will help us to extend our leadership at the forefront of skin optics and machine learning, ensuring MedX solutions remain both clinically rigorous and commercially scalable.”

About MedX Health Corp.

MedX Health Corp., headquartered in Ontario, Canada, is a leader in non-invasive skin assessment and teledermatology. Its proprietary SIAscopy® technology, integrated into the DermSecure® platform, enables pain-free, accurate imaging of skin lesions for rapid dermatologist review. These products are cleared by Health Canada, the U.S. Food and Drug Administration, the Therapeutic Goods Administration and Conformité Européenne, for use in 38 territories worldwide including Canada, the U.S., Australia, New Zealand, the United Kingdom, the European Union and Turkey. MedX’s advanced telemedicine platform enables healthcare professionals to quickly and accurately assess suspicious moles, lesions, and other skin conditions through its proprietary imaging technology, SIAscopy®, and its secure, cloud-based patient management system, DermSecure®.

Visit: https://www.medxhealth.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This Media Release may contain forward-looking statements, which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties.

More News From MedX Health Corp.

, /PRNewswire/ -- CenterPoint Energy, Inc.'s (NYSE: CNP) Board of Directors today declared a regular quarterly cash dividend of $0.2200 per share on the issued and outstanding shares of Common Stock payable on December 11, 2025, to shareholders of record at the close of business on November 20, 2025.

About CenterPoint Energy, Inc.
CenterPoint Energy, Inc. (NYSE: CNP) is a multi-state electric and natural gas delivery company serving approximately 7 million metered customers across Indiana, Minnesota, Ohio, and Texas. The company is headquartered in Houston and is the only Texas-domiciled investor-owned utility. As of June 30, 2025, the company owned approximately $44 billion in assets. With approximately 8,300 employees, CenterPoint Energy and its predecessor companies have been serving customers for more than 150 years.

For more information, contact
Communications
[email protected]

SOURCE CenterPoint Energy, Inc

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In

PSQ Holdings, Inc. (NYSE:PSQH) Analyst/Investor Day September 25, 2025 11:00 AM EDT

Company Participants

William Kent - Senior Vice President of Corporate Affairs
Michael Seifert - Founder, President, CEO & Chairman of the Board
Dustin Wunderlich - Chief Strategy Officer & DIrector
Caitlin Long - PublicSquare Board member, Founder and CEO of Custodial Bank
Brian Billingsley - President of Fintech
Alex Bruesewitz - President of PSQ Impact and Founder of X Strategies
Ben McMillan - Founder and CIO of IDX Advisors
James Rinn - CFO, Treasurer & Director

Presentation

William Kent
Senior Vice President of Corporate Affairs

Good morning, and welcome to the PublicSquare 2025 Analyst and Investor Day. Thank you for joining us this morning. My name is William Kent. I'm the SVP of Corporate Affairs at Public Square, and it's my pleasure to get things started today. Before we begin, I'd like to bring to your attention the following forward-looking cautionary statements, and we ask you to review these statements and language in its entirety. We'd like to emphasize that the information discussed during this meeting, including our outlook, is based on current information as of today and contains forward-looking statements that involve risks, uncertainties and assumptions.

We undertake no duty or obligation to update such statements as a result of new information or future events. Please refer to today's investor deck and our SEC filings, including our 2024 10-K for factors that may cause actual results to differ materially from our forward-looking statements. We'd also like to point out that we may present non-GAAP measures in addition and not as a substitute for financial measures calculated in accordance with GAAP.

With that out of the way, I'd like to introduce you to today's speakers. Joining me today in the studio are Michael Seifert, Founder and CEO of PublicSquare; and James Rinn, our Chief Financial Officer and a Board member. Joining

Recommended For You

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

September 25, 2025 10:00 PM EDT | Source: WildBrain Ltd.
Q4 and Fiscal 2025 Operational Highlights

Global Licensing delivered strong growth in Fiscal 2025, reflecting both the breakout performance of owned IP and the continued momentum of WildBrain CPLG, which expanded with new partners and deepened long-term relationships.With our owned brands, Strawberry Shortcake revenue grew nearly 200% year over year to become a meaningful contributor with clear upside, Peanuts recorded its strongest year ever with broad-based global demand for a record-breaking year, and Teletubbies delivered double-digit gains supported by new activations and preparations for its 30th anniversary.Q4 Financial Highlights1

Revenue including Canadian Television Broadcasting ("Television") was $139.1 million, up 7% year over year. Revenue excluding Television was $129.4 million, up 6% year over year. Net income including Television was $9.5 million, compared with net loss of $80.7 million in Q4 2024. Net income excluding Television was $11.2 million, compared with net loss of $17.0 million in Q4 2024. Adjusted EBITDA2 including Television was $24.6 million, up 3% year over year. Adjusted EBITDA excluding Television was $19.1 million, down 1% year over year. Cash used in operating activities was $2.0 million, compared to cash provided by operating activities of $18.3 million in Q4 2024.Free Cash Flow3 was negative $17.3 million, compared to negative $6.6 million in Q4 2024. Fiscal 2025 Financial Highlights

Revenue including Television was $523.4 million, up 13% year over year. Revenue excluding Television was $487.3 million, up 14% year over year.Net loss including Television was $89.8 million, compared with net loss of $106.0 million in FY 2024. Net loss excluding Television was $97.6 million, compared with net loss of $58.2 million in FY 2024.Adjusted EBITDA including Television was $92.3 million, up 5% year over year. Adjusted EBITDA excluding Television was $68.6 million, up 3% year over year. Cash provided by operating activities was $152.5 million, compared to cash provided by operating activities of $73.6 million in FY 2024.Free Cash Flow was positive $49.5 million, compared to negative $29.5 million in FY 2024. Toronto, Ontario--(Newsfile Corp. - September 25, 2025) - WildBrain Ltd. (TSX: WILD) ("WildBrain" or the "Company"), a global leader in kids' and family entertainment, today reported its full year and fourth quarter ("Q4 2025") results for the period ended June 30, 2025.

Josh Scherba, WildBrain President and CEO, said: "Fiscal 2025 was a pivotal year for WildBrain as we sharpened our focus on our premium franchises and delivered strong growth across our Global Licensing business. We demonstrated the resilience of our 360-degree franchise strategy across Content Creation, Audience Engagement and Global Licensing as we continued to grow love for Peanuts, Strawberry Shortcake and Teletubbies with fans of all ages worldwide. Our financial discipline led to improved free cash flow and a reduction in leverage over the course of the year."

"As previously announced, we made the difficult decision to exit the Canadian broadcast television business, a step which reflects the realities of the evolving market and our commitment to concentrating resources on higher-margin, higher-growth opportunities that are shaping the future of kids' and family entertainment. With this focus, we are well-positioned to build on our momentum in fiscal 2026 and create long-term value for shareholders."

Nick Gawne, WildBrain CFO, added: "In Fiscal 2025, our focus on our core brands, our investments in high-growth areas and our continued financial discipline drove growth in revenue, adjusted EBITDA and Free Cash Flow. Looking to Fiscal 2026, we expect that story to continue with strong underlying growth in the core business, driven by doubling down on high-growth areas alongside continued focus on operating efficiency."

Fiscal Year 2026 Outlook

In Fiscal Year 2026, the Company will cease operations of its Television business. To provide comparable results, the Company is providing its outlook both including and excluding Television.

In Fiscal Year 2026, for results including Television, we expect:

Revenue of approximately $560 million to $590 million andAdjusted EBITDA of approximately $80 million to $85 million.In Fiscal Year 2026, for results excluding Television, we expect:

Revenue growth of approximately 15% to 20% andAdjusted EBITDA growth of approximately 15% to 20%. Q4 2025 Financial Highlights including Television1

In Q4 2025, revenue increased 7% to $139.1 million, compared to $130.0 million in Q4 2024.

Global Licensing revenue increased 29% to $69.4 million in Q4 2025, compared to $53.7 million in Q4 2024. Revenue in the quarter was driven by strong growth in our owned brands-Peanuts, Strawberry Shortcake and Teletubbies-supplemented by third party revenue growth from our global licensing agency, WildBrain CPLG.

Content Creation and Audience Engagement revenue decreased 12% to $60.0 million in Q4 2025, compared to $68.0 million in Q4 2024. Revenue in the quarter was driven by a reduction in distribution revenues, offset by stronger production revenue as compared to the prior year's quarter.

Gross margin for Q4 2025 was 45%, compared to gross margin of 46% in Q4 2024. Gross margin for Q4 2025 was $63.3 million, an increase of $3.7 million, compared to $59.5 million for Q4 2024.

Cash used in operating activities in Q4 2025 was $2.0 million, compared to $18.3 million cash provided by operating activities in Q4 2024. Free Cash Flow was negative $17.3 million in Q4 2025, compared with Free Cash Flow of negative $6.6 million in Q4 2024. Fiscal year 2025 Free Cash Flow was positive $49.5 million, compared to negative $29.5 million in the prior fiscal year.

Adjusted EBITDA increased 3% to $24.6 million in Q4 2025, compared with $23.9 million in Q4 2024.

Q4 2025 net income was $9.5 million, compared to net loss of $80.7 million in Q4 2024.

Leverage in Q4 2025 was 4.76x, comfortably within our financial covenants.

Financial Highlights
(in millions of Cdn$)
Twelve Months Ended
June 30,

2025

2024

2025

2024

2025

2024
Consolidated Results Excluding WildBrain Television Broadcast Operations

WildBrain Television Broadcast Operations

Consolidated Results Including WildBrain Television Broadcast OperationsRevenue
$487.3

$426.4

$36.1

$35.4

$523.4

$461.8Cost of Sales
$(272.7)

$(231.5)

$(7.5)

$(9.2)

$(280.2)

$(240.7)Gross Margin
$214.6

$194.8

$28.6

$26.3

$243.2

$221.1SG&A
$(106.8)

$(97.0)

$(4.9)

$(5.4)

$(111.7)

$(102.4)Adjusted EBITDA
$107.7

$97.8

$23.7

$20.9

$131.4

$118.7Portion of Adjusted EBITDA attributable to NCI
$(39.1)

$(31.1)

$—

$—

$(39.1)

$(31.1)Adjusted EBITDA attributable to WildBrain
$68.6

$66.7

$23.7

$20.9

$92.3

$87.6In December 2024, the Company announced that it had signed a definitive agreement ("the Sale Agreement") to sell 66 2/3% of its Canadian Television Broadcasting ("Television") and that in accordance with IFRS 5: Non-current Assets Held for Sale and Discontinued Operations, the results of Television were presented as discontinued operations during the second and third quarters of 2025. In the Q3 financial statements, the Company disclosed that as a result of Bell's decision to cancel Television channels, the Company was renegotiating certain elements of the Sale Agreement. At June 30, 2025, the Company determined that the sale of Television no longer met the threshold set out in IFRS 5 of being highly probable and as a result, reinstated the Television segment into held-for-use. In August 2025, the Company announced that it would be ceasing operation of Television later this year. Until the cessation occurs, Television will be reported in net income from operations. In Q2 2026, Television will return to discontinued operations. The Company is presenting its results isolating Television from its continuing businesses to provide a consistent and clear view of both the Company's core continuing operations and total operations in the applicable periods.Free Cash Flow, Gross Margin, Adjusted EBITDA and Adjusted EBITDA attributable to WildBrain are non-GAAP financial measures - see below for further details.Free Cash Flow includes discontinued operations.Q4 2025 Conference Call

The Company will hold a conference call on September 26, 2025 at 10:00 a.m. ET to discuss the results.

To listen online, please visit the following link: https://www.gowebcasting.com/14355

To listen by phone, please dial 1-844-763-8274 in North America (toll free) or +1 647-484-8814 internationally (tolls apply). If dialing in, please allow 10 minutes to be connected to the conference call.

Replay will be available at the above link or by dialing 1-855-669-9658 in North America (toll free) or +1 412-317-0088 internationally (tolls apply), until October 26, 2025, using access code 3699353.

The audio and transcript will also be archived on WildBrain's website approximately three business days following the call.

About WildBrain

At WildBrain we inspire imaginations through the wonder of storytelling. A leader in 360° franchise management-spanning Content Creation, Audience Engagement and Global Licensing-our mission is to cultivate and grow love for our own and partner brands through exceptional entertainment experiences. Home to such franchises as Peanuts, Teletubbies, Strawberry Shortcake, Yo Gabba Gabba!, Inspector Gadget and Degrassi, we produce such acclaimed series as The Snoopy Show, Snoopy in Space, Camp Snoopy, Teletubbies Let's Go!, Yo Gabba GabbaLand!, Sonic Prime and Strawberry Shortcake: Berry in the Big City. With a library of approximately 14,000 half-hours, our shows reach kids and families everywhere, including on our YouTube network, which has generated more than 1.7 trillion minutes of watch time. Our consumer products licensing arm, WildBrain CPLG, represents our own and partner brands in every major territory worldwide. Headquartered in Toronto, WildBrain trades on the Toronto Stock Exchange, (TSX: WILD). Visit us at wildbrain.com.

Forward-Looking Statements

This press release may contain forward-looking information within the meaning of applicable securities legislation, which reflects WildBrain's current assumptions and expectations regarding future events as at the time they are made. The words "will", "expects", "anticipates", "believes", "plans", "intends" and similar expressions are often intended to identify forward-looking information, although not all forward-looking information contains these identifying words. Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. Forward-looking information is based on a number of assumptions and is subject to a number of risks and uncertainties, many of which are beyond WildBrain's control, which could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking information. Such risks and uncertainties include but are not limited to: changes in general economic, business and political conditions. WildBrain undertakes no obligation to update such forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Non-IFRS Measures

In addition to the results reported in accordance with IFRS as issued by the International Accounting Standards Board, the Company uses various non-GAAP financial measures, which are not recognized under IFRS, as supplemental indicators of our operating performance and financial position. These non-GAAP financial measures are provided to enhance the user's understanding of our historical and current financial performance and our prospects for the future. Management believes that these measures provide useful information in that they exclude amounts that are not indicative of our core operating results and ongoing operations and provide a consistent basis for comparison between periods. The following discussion explains the Company's use of certain non-GAAP financial measures, which are Adjusted EBITDA, Adjusted EBITDA attributable to the Shareholders of the Company, Gross Margin and Free Cash Flow.

Investors are cautioned that these non-GAAP financial measures should not be construed as an alternative measure to net income or loss, or other measures as determined in accordance with GAAP, or as an indicator of the Company's financial performance or a measure of liquidity and cash flows.

"Adjusted EBITDA" means earnings (loss) before net finance costs, income taxes, amortization of property & equipment and right-of-use and intangible assets, amortization of acquired and library content, equity-settled share-based compensation expense, changes in fair value of embedded derivatives, gain/loss on foreign exchange, reorganization, development and other expenses, impairment of certain investments in film and television programs/acquired and library content/P&E/intangible assets/goodwill, and also includes adjustments for other identified charges, as specified in the accompanying tables. Adjusted EBITDA is not an earnings measure recognized by GAAP and does not have a standardized meaning prescribed by GAAP; accordingly, Adjusted EBITDA may not be comparable to similar measures presented by other issuers. Management believes that certain lenders, investors and analysts use Adjusted EBITDA to measure a company's ability to service debt and meet other payment obligations, and as a common valuation measurement in the media and entertainment industry. Further, certain of our debt covenants use Adjusted EBITDA in the calculation. The most comparable GAAP measure is earnings before income taxes.

"Adjusted EBITDA attributable to the Shareholders of the Company" means Adjusted EBITDA excluding the portion of Adjusted EBITDA attributable to non-controlling interests.

"Gross Margin" means revenue less direct production costs and expense of film and television produced. Gross Margin is not an earnings measure recognized by GAAP and does not have a standardized meaning prescribed by GAAP; accordingly, Gross Margin may not be comparable to similar measures presented by other issuers. Management believes Gross Margin is a useful measure of profitability before considering operating and other expenses and can be used to assess the Company's ability to generate positive net earnings and cash flows. The most comparable GAAP measure is gross profit.

"Free Cash Flow" means operating cash flow less distributions to non-controlling interests, changes in interim production financing, cash interest paid on our long-term debt, bank indebtedness, and lease liabilities, and principal repayments on our lease liabilities. Free Cash Flow does not have a standardized meaning prescribed by GAAP; accordingly, Free Cash Flow may not be comparable to similar measures presented by other issuers. Management believes Free Cash Flow is a useful measure of the Company's ability to repay debt, finance strategic business acquisitions and investments, pay dividends, and repurchase shares. The most comparable GAAP measure is cash from operating activities.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/268009

NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of CTO Realty Growth, Inc. (NYSE: CTO, CTO-PA) between February 18, 2021 and June 24, 2025, both dates inclusive (the “Class Period”), of the October 7, 2025 lead plaintiff deadline.

SO WHAT: If you purchased CTO Realty securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the CTO Realty class action, go to https://rosenlegal.com/submit-form/?case_id=43344 or call Phillip Kim, Esq. at 866-767-3653 or email [email protected] for more information. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 7, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made false and misleading statements and/or failed to disclose that: (1) CTO’s dividends were less sustainable than defendants had led investors to believe; (2) CTO Realty Growth used deceptive and unsustainable practices to artificially inflate its Adjusted Funds from Operations (“AFFO”) and overstate the true profitability of its Ashford Lane property; (3) accordingly, CTO Realty Growth’s business and/or financial prospects were overstated; and (4) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the CTO Realty class action, go to https://rosenlegal.com/submit-form/?case_id=43344 or call Phillip Kim, Esq. at 866-767-3653 or email [email protected] for more information.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        [email protected]
        www.rosenlegal.com

SummaryAir France-KLM posts a good earnings review for H1 2025; however, the underlying financials should be studied before forming an opinion.The company trades at a lower P/E and EV/EBITDA than industry peers, suggesting potential undervaluation, but is this a value trap?Revenue growth and revenue per available tonne kilometre are lacklustre compared to European competitors.Using a Monte Carlo simulation, we can reliably evaluate the market position of AFRAF, weighing in fuel price action affecting earnings compared to the long-term FCF outlook.BrasilNut1/iStock Editorial via Getty Images

When it comes to European air travel, Air France and KLM are almost omnipresent, from small regional airports to large international routes. But so was Pan Am in its heyday. As smart investors, you should always stay on your toes, which

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Cytokinetics, Inc. (NASDAQ: CYTK) between December 27, 2023 and May 6, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 17, 2025.

SO WHAT: If you purchased Cytokinetics common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Cytokinetics class action, go to https://rosenlegal.com/submit-form/?case_id=45298 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 17, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.s

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements regarding the timeline for the New Drug Application (“NDA”) submission and approval process for aficamten. Specifically, defendants represented that Cytokinetics expected approval from the U.S. Food and Drug Administration (“FDA”) for its NDA for aficamten in the second half of 2025, based on a September 26, 2025 Prescription Drug User Fee Act (“PDUFA”) date, and failed to disclose material risks related to Cytokinetics’ failure to submit a Risk Evaluation and Mitigation Strategy (“REMS”) that could delay the regulatory process. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Cytokinetics class action, go to https://rosenlegal.com/submit-form/?case_id=45298 call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        [email protected]
        www.rosenlegal.com

SAN DIEGO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that the C3.ai class action lawsuit – captioned Liggett v. C3.ai, Inc., No. 25-cv-07129 (N.D. Cal.) – seeks to represent purchasers or acquirers of C3.ai, Inc. (NYSE: AI) securities and charges C3.ai as well as certain of C3.ai’s executives with violations of the Securities Exchange Act of 1934.

If you suffered substantial losses and wish to serve as lead plaintiff of the C3.ai class action lawsuit, please provide your information here:

https://www.rgrdlaw.com/cases-c3-ai-class-action-lawsuit-ai.html

You can also contact attorneys J.C. Sanchez or Jennifer N. Caringal of Robbins Geller by calling 800/449-4900 or via e-mail at [email protected]. Lead plaintiff motions for the C3.ai class action lawsuit must be filed with the court no later than Tuesday, October 21, 2025.

CASE ALLEGATIONS: C3.ai operates as an enterprise artificial intelligence (“AI”) application software company.

The C3.ai class action lawsuit alleges that defendants created the false impression that they possessed reliable information pertaining to C3.ai’s projected revenue outlook and anticipated growth while also minimizing risk to C3.ai’s profitability from defendant CEO Thomas M. Siebel’s health concerns. In truth, according to the complaint, C3.ai’s optimistic reports of growth, earnings potential, and anticipated margins fell short of reality as they relied far too heavily on the health and effectiveness of C3.ai’s CEO.

The C3.ai class action lawsuit further alleges that on August 8, 2025, C3.ai announced disappointing preliminary financial results for the first quarter of fiscal year 2026 and reduced its revenue guidance for the full fiscal year 2026, attributing its poor sales results and lowered guidance on “the reorganization with new leadership” and the health ailments of its CEO. On this news, the price of C3.ai stock fell more than 25%, according to the complaint.

THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired C3.ai securities during the Class Period to seek appointment as lead plaintiff in the C3.ai class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the C3.ai class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the C3.ai class action lawsuit. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the C3.ai class action lawsuit.

ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world’s leading law firms representing investors in securities fraud and shareholder litigation. Our Firm has been ranked #1 in the ISS Securities Class Action Services rankings for four out of the last five years for securing the most monetary relief for investors. In 2024, we recovered over $2.5 billion for investors in securities-related class action cases – more than the next five law firms combined, according to ISS. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs’ firms in the world, and the Firm’s attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig. Please visit the following page for more information:

https://www.rgrdlaw.com/services-litigation-securities-fraud.html

Past results do not guarantee future outcomes. 
Services may be performed by attorneys in any of our offices. 

Contact:
        Robbins Geller Rudman & Dowd LLP
        J.C. Sanchez, Jennifer N. Caringal
        655 W. Broadway, Suite 1900, San Diego, CA 92101
        800-449-4900
        [email protected]

Ethereum remains one of the most closely watched assets in crypto markets, with analysts projecting a potential price target of $7,000 by 2026. Institutional adoption, Layer-2 expansion, and Ethereum's pivotal role in DeFi and tokenization are driving optimism.

Journalist

Posted: September 26, 2025

Key Takeaways 
Why does a VC believe Lee’s bullish projection is ‘retarted’?
Andrew Kang argued that the tokenized market has already exploded 1000x, but hasn’t boosted ETH

Will ETH drop to $1K per Kang’s projection? 
The future is hard to predict. But a crucial ETH support and realized price for accumulation addresses was at $2.8K. 

A VC partner has projected that the Ethereum [ETH] price could remain range-bound between $1K-$4K for an extended period, discrediting Fundstrat CIO Tom Lee’s bullish thesis and $60K price target.

In an X (formerly Twitter) post on the 24th of September, Andrew Kang, a partner at Mechanism Capital, called Lee’s projection ‘retarded.’ 

He downplayed Lee’s positive ETH outlook based on tokenization and stablecoin narratives.

He added that the tokenized market has grown, 1000x since 2020, but daily transaction fees on Ethereum have remained at a five-year low. 

“Tom’s argument fundamentally misunderstands how value accrual works and may lead you to believe that fees would scale proportionally, but in fact, they are practically at the same level of  2020.”

Source: X

Banks won’t buy ETH, says Kang
Kang added that large banks and institutions haven’t bought ETH and won’t make a bid in the future, as Lee expects. He drew parallels with oil, adding that banks only ‘pay for it when they need it.’

For the unfamiliar, crypto treasury firms led by Lee’s BitMine have accumulated $21 billion worth of the ETH, partly driven by the expected stablecoin and tokenization boom.

In fact, this new demand line lifted ETH from $1.5K to nearly $5K in 2025, about a 200% rally. Hence, more demand from such institutions could boost the ecosystem. 

But Kang was right on one thing – other blockchains will capture the tokenization boom. In fact, the growing competition from stablecoin-focused chains with more distribution channels could eat into ETH’s market share. 

Even so, it may be too early for the bearish bet for ETH. In fact, earlier in the year, Kang projected that ETH could slip below $1K; instead, the altcoin rallied 3x. 

That said, ETH accumulation addresses have hit a record high of 27.3 million ETH. Coupled with a looming supply crunch, the backdrop could be positive for ETH. This could raise the odds for a $5K price target. 

Source: CryptoQuant 

However, in the case of an extreme bearish scenario as projected by Kang, the key support to watch would be $2.8K.

It doubled as the realized price for accumulation addresses and stopped the H1 2025 pullback. 

Source: CryptoQuant

XRP Seoul 2025 sent shockwaves through the crypto world as over 3,000 global attendees unveiled major staking, tokenization, and real-world asset breakthroughs for the XRPL.

Why do XRP traders need to worry about BTC and ETH option expiries?

BTC option market makers and whales typically push prices toward the ‘max pain’ level ahead of the expiration date. The ‘max pain’ level is the price point where the largest number of options expire worthless. By pushing BTC below the ‘max pain’ level, options sellers minimize payouts and maximize profits. This is referred to as the Max Pain Theory.

BTC’s dominance influences broader market sentiment and buyer demand for XRP. A BTC sell-off typically triggers an XRP reversal, overshadowing positive developments.

This quarter, upbeat US labor market and GDP data tempered expectations of multiple Fed rate cuts in the fourth quarter, adding to the market angst. Traders locked in profits ahead of today’s US Personal Income and Outlays Report. Hotter inflation could further impact hopes for policy easing in the fourth quarter, weighing on risk assets.

XRP has previously experienced volatility in response to US economic data, Fed forward guidance, and FOMC interest rate decisions. For context, XRP slid 5.01% on Friday, August 29, in response to July’s better-than-expected Personal Income and Outlays Report.

Tailwinds Gather, Signaling an October Rebound
Despite XRP facing selling pressure in late September, upcoming events could set the token up for a bullish fourth quarter.

The launch of XRP-spot ETFs, including a potential iShares XRP Trust, may fuel institutional demand and send XRP to new highs.

Nate Geraci, president at NovaDius Wealth Management, spoke with Robbie Mitchnick, head of digital assets at BlackRock (BLK), about the crypto-spot ETF market.

Mitchnick noted that the biggest factors in deciding on a product launch are the level of investor demand and what problem is BlackRock solving for them, adding:

“So, when we think about other potential opportunities in this space, obviously we’re looking at things like market cap, liquidity, maturity, but also clarity of investment thesis and overall product and portfolio considerations in terms of how clients’ long-term are going to be able to use products in this space, build the type of portfolio exposures holistically that they want. And so, that’s a constant evaluation process. It’s not a fixed point in time thing, but ultimately that’s the kind of process that we employ.”

With XRP being the third largest crypto by market cap and considering the success of iShares Bitcoin Trust (IBIT) and iShares Ethereum Trust (ETHA), an iShares XRP Trust remains a possibility.

However, Bloomberg Intelligence Senior ETF Analyst Eric Balchunas downplayed the chances of an iShares XRP Trust filing, stating:

“Given all the other coins about to ETF-ized, it’s notable BlackRock is going another bitcoin product, imo, signifies they are going to build around btc and eth and lay off the rest, at least for now. This makes the horse race for these other coins much more wide open. No Secretariat to contend with.”

BlackRock filed for a Bitcoin Premium Income ETF on Thursday, September 25, established to yield income rather than offer direct exposure to BTC price trends. The filing aligns with Balchunas’s view that BlackRock will focus on BTC and ETH rather than other cryptos.

However, strong demand for XRP-spot ETFs could shift the narrative. Seven XRP-spot ETFs await the SEC’s decision, with final decision deadlines ranging from October 18 and November 14.

Price Action & Technical Analysis: Breach $2.7 or Break $3
XRP slid 6.22% on Thursday, September 25, reversing the previous session’s 3.57% gain to close at $2.7453. The token underperformed the broader market (-4.47%) on its drop toward key support levels. Traders are watching the following technical levels:

Support: $2.7 and $2.5.
Resistance: $2.8, $3, $3.2, $3.335, and the all-time high at $3.66.

In the near term, several key events could drive price action:

US Personal Income and Outlays Report
XRP ETF demand.
Spot ETFs: Approval or delays of XRP-spot ETFs and BlackRock’s position on an iShares XRP Trust filing.
Blue-chip companies’ positions on XRP as a treasury reserve asset.
Regulatory milestones: Ripple’s US-chartered bank license application, the Market Structure Bill, and SWIFT-related news may also influence sentiment.

Catalysts & Scenarios
The balance of US economic data, ETF flow trends, regulatory developments, and institutional demand could dictate whether XRP breaches lower support levels or breaks above resistance.

Bearish Scenario

Hotter-than-expected US Core PCE Index data.
GDLC, BITW, and XRPR ETFs register weak inflows or outflows, and BlackRock stays silent on an iShares XRP Trust filing.
SEC rejects XRP-spot ETF applications.
Legislative roadblocks or resistance to crypto-friendly regulations.
Blue-chip companies dismiss XRP as a treasury reserve asset.
OCC delays or rejects Ripple’s US-chartered bank license.
SWIFT retains market share in global remittances, curbing Ripple’s market access.

These bearish events could drag XRP toward $2.7. If breached, $2.5 would be the next key support level.

Bullish Scenario

Softer US inflation.
BITW, GDLC, and XRPR register strong inflows.
BlackRock files for an iShares XRP Trust, and the SEC approves XRP-spot ETFs.
Blue-chip companies purchase XRP for treasury purposes, and more payment platforms integrate Ripple technology.
Ripple secures a US-chartered bank license, and the Senate passes the Market Structure Bill.
SWIFT loses market share of global remittances to Ripple.

These catalysts could send XRP toward $2.8. A break above $2.8 may enable the bulls to target $3. A sustained move through $3 could pave the way toward $3.2.

55 minutes ago

BlackRock filed a registered trust company to back its proposed Bitcoin Premium Income ETF, a yield-generating product that would complement its $87 billion spot Bitcoin ETF, IBIT.

784

Asset management giant BlackRock filed to register a Delaware trust company for its proposed Bitcoin Premium Income ETF on Thursday, signaling a push to broaden its Bitcoin offerings.

Bloomberg ETF analyst Eric Balchunas said BlackRock’s proposed product would sell covered call options on Bitcoin futures, collecting premiums to generate yield. 

The regular distributions would, however, trade away potential upside from investing in BlackRock’s spot Bitcoin ETF, which mirrors Bitcoin’s (BTC) price movements. 

“This is a covered call Bitcoin strategy in order to give BTC some yield. This will be a ’33 Act spot product, sequel to the $87b $IBIT.”Registering a trust filing in Delaware typically indicates that an ETF issuer will imminently file an S-1 registration statement or 19b-4 filing with the Securities and Exchange Commission to officially kick off the process.

Details of BlackRock’s iShares Bitcoin Premium Income ETF filing. Source: Delaware
US regulators — particularly the SEC — have signaled openness to a wider range of crypto investment products as part of President Donald Trump’s promise to make America the “crypto capital of the world.”

The new BlackRock product would complement its iShares Bitcoin ETF (IBIT), which has clocked over $60.7 billion in inflows since launching in January 2024 — by far the largest of its kind — with the Fidelity Wise Origin Bitcoin Fund (FBTC) coming in next at $12.3 billion.

Bitcoin yield products are slowly coming to marketOne of the earliest reasons why many TradFi investment companies overlooked Bitcoin is that it isn’t a native yield-generating asset.

However, solutions have popped up, such as one of Strategy’s convertible preferred stock offerings, STRK, which leverages its 639,835 Bitcoin to offer investors stable income.

If approved, BlackRock’s proposed product would add to the few prominent yield-generating Bitcoin products in the US.

BlackRock won’t take part in altcoin ETF craze, analyst saysBalchunas said that, in light of all the other coins “about to be ETF-ized,” the filing shows BlackRock is opting to build around Bitcoin and Ether (ETH) and “lay off the rest, at least for now.”

“This makes the horse race for these other coins much more wide open,” he said.

Potential approvals may start coming in quicker too, with the SEC last week approving a generic listing standard that wouldn’t require each application to be assessed individually.

Among the cryptocurrencies most likely to next be wrapped in ETF form are Litecoin (LTC), Solana (SOL), XRP (XRP) and Dogecoin (DOGE).

Magazine: ‘Help! My robot vac is stealing my Bitcoin’: When smart devices attack

Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure

Midas, in partnership with Axelar, has launched the first XRP liquid staking token, mXRP. The token will provide investors with yields from the XRP DeFi ecosystem and further expand the altcoin’s utility. 

XRP Liquid Staking Token Launches
Midas revealed that the mXRP liquid staking token will be issued on the XRP Ledger EVM via the Axelar bridge, which also facilitates the transfer of the token to the Ledger. The tokenization platform noted that this is a first-of-its-kind tokenized exposure product, offering meaningful XRP-denominated yield strategies. The token is expected to provide an APY of up to 8% for holders, although Axelar indicated it could reach 10%.

In an X post, Panek Mekras, co-founder of Anodos Finance, which offers the token on the Ledger, broke down key details about the liquid staking token. He explained that token is a yield-bearing version of XRP that generates yields for its holders. As such, the price of mXRP should continuously grow against the XRP price and trade at a premium. 

Panek further stated that the yield comes from various strategies, including lending, market making, and depositing on DeFi protocols, among others. He noted that asset managers first lock XRP and then borrow against it in stablecoins, using the capital for various strategies to generate profits. 

The Anodos Finance co-founder also clarified that investors simply need to hold the staking token to claim their yields or redeem their XRP. He added that holders of the liquid staking token do not receive extra tokens. Instead, the yield and rewards are automatically added and embedded into mXRP’s value. 

Panek noted that token works similarly to other liquid staking tokens, such as stETH, jitoSOL, and sAVAX, meaning that those looking to get yields from it have to buy the asset and hold it. They can do this by selling XRP or adding new capital to buy the token. 

Panek indicated that the launch of mXRP is beneficial for XRP, as it will add constant buying pressure to the altcoin. He noted that Midas and Axelar said that the goal is to become a perpetual buyer of XRP. Meanwhile, every XRP used to mint mXRP is locked, thereby removing it from circulation. 

Flare Network also recently announced the launch of ‘FXRP’ to expand XRP’s DeFi. Panek noted that mXRP and FXRP are slightly different, but ultimately, both are beneficial for XRP and the XRP Ledger. mXRP’s capital is managed by asset managers who generate yield on behalf of investors. At the same time, FXRP is a trustless version of XRP on the Flare network, which doesn’t inherently generate yield but can be used in DeFi protocols to generate yields.

At the time of writing, the altcoin price is trading at around $2.84, down in the last 24 hours, according to data from CoinMarketCap.

XRP trading at $2.84 on the 1D chart | Source: XRPUSDT on Tradingview.com
Featured image from iStock, chart from Tradingview.com

Editorial Process for bitcoinist is centered on delivering thoroughly researched, accurate, and unbiased content. We uphold strict sourcing standards, and each page undergoes diligent review by our team of top technology experts and seasoned editors. This process ensures the integrity, relevance, and value of our content for our readers.

Sign Up for Our Newsletter!
For updates and exclusive offers enter your email.

Scott Matherson is a leading crypto writer at Bitcoinist, who possesses a sharp analytical mind and a deep understanding of the digital currency landscape. Scott has earned a reputation for delivering thought-provoking and well-researched articles that resonate with both newcomers and seasoned crypto enthusiasts.
Outside of his writing, Scott is passionate about promoting crypto literacy and often works to educate the public on the potential of blockchain.

Cover image via www.freepik.com

Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.

The market is expiriencing somewhat of a storm as Shiba Inu, Ethereum and Bitcoin are losing multiple key support levels, and there is a good possibility of an aggravation here as no fresh inflows are present and most of the volume on the market is on the selling side. 

Shiba Inu loses key supportThe price of Shiba Inu has fallen below important support levels, indicating that a retest of the $0.00001 bottom may be closer than many anticipated. This indicates that the stock is once again under strong selling pressure. According to the asset's current structure, if sentiment and technicals do not rapidly improve, the asset may be headed for new 2025 lows. The symmetrical triangle structure that had previously kept the price of SHIB stable for months has now been broken on the daily chart. 

SHIB/USDT Chart by TradingViewThe token broke because it was unable to hold above the 50-day and 100-day EMAs, making it susceptible to additional drops. There is still momentum working against bulls because the 200-day EMA is likewise sloping downward. Previously a dependable short-term floor, the $0.0000122 support zone is now resistance as bears gain ground. Red candles have seen an increase in volume, suggesting that sellers are growing more confident.

HOT Stories

Although the RSI has entered oversold territory, it has not yet indicated a reversal, suggesting that the downward momentum may continue. SHIB may be headed for a test of $0.0000115 if the current circumstances continue with the possibility of a decline to the psychological $0.00001 level. In addition to representing a retest of SHIB's annual lows, such a decline might put the asset in danger of breaching its larger 2025 support range. Recovery appears to be difficult for now.

Ethereum stumblesThe fact that Ethereum has dropped below the crucial $4,000 mark suggests that the market as a whole is weak and that more declines are likely. The decline occurred quickly after ETH failed to maintain its consolidation around the $4,400-$4,500 resistance zone, and bearish pressure took over.

Since its recent symmetrical triangle formation, ETH has been declining sharply, according to the daily chart. With sellers taking charge, this breakdown demonstrates that there is no buying support at higher levels. The bearish move has gained more weight as trading volumes have increased during the decline.

ETH/USDT Chart by TradingViewThe Relative Strength Index, meanwhile, has dipped nearer to oversold territory, indicating that bearish momentum may yet worsen before a relief bounce takes place. Ethereum is in a precarious position right now, trading just below $4,000.

The next significant area of interest, if selling persists, is around the 100-day EMA, which is close to $3,833. This moving average has historically served as a dependable level of support during periods of correction, so buyers may intervene there to protect against further losses. Ethereum might level off and try to push back toward $4,200 if the 100 EMA holds.

It is impossible to rule out a more aggressive move toward the $3,600-$3,400 range if this support fails. The 200 EMA would then be the crucial last line of defense to prevent a protracted bearish cycle further below it, at $3,392.

For the time being, Ethereum’s failure to hold the $4,000 mark is a serious setback to bullish sentiment. Investors should closely monitor ETH’s response to the $3,833 mark in the upcoming sessions. Hopes for a midterm recovery could be raised by a strong bounce here, but failure would pave the way for a more significant correction.

Bitcoin pattern recognizedA head and shoulders pattern could determine whether the next move is a surge toward $123,000 or a plunge into bearish territory, which may be its most important formation of the year.

On the daily chart, the pattern has been gradually developing, with Bitcoin settling between $112,000 and $114,000 following several unsuccessful attempts to rise. Bitcoin is currently trading just above the 100 EMA, and the pattern’s neckline is a crucial support level.

The bullish head and shoulders scenario could be confirmed by a clear breakout above the $114,000 resistance, which would pave the way for a medium-term move to $123,000. This level is the next logical target for bulls, since it is where breakout traders and upside liquidity are likely to converge.

But prudence is still necessary. The danger of a decline will increase rapidly if the pattern does not finish and Bitcoin drops below the neckline. The next important level of support is the 200 EMA, which is presently trading at about $106,000. A decline to that level would push the market into a bearish narrative and put investor confidence to the test, even though this would still keep Bitcoin above its longer-term bullish structure.

Hesitance is also suggested by volume trends: selling spikes imply that whales are offloading at every rally attempt, and buying pressure has not been strong enough to break through resistance levels.

The SEC delayed action on Canary's SUI and PENGU funds, along with staked INJ and SEI funds, and some spot Avalanche proposals.

Major global firms are pushing XRP into the corporate mainstream with a bold new platform set to revolutionize treasury management and digital payments worldwide.

FalconX, a leading digital asset prime broker, has executed the first forward rate agreements (FRAs) tied to Ethereum staking yields, marking a major step in building a fixed-income layer for crypto markets. The development provides institutional investors with a way to hedge or speculate on Ethereum's native yield, which has grown increasingly volatile amid record demand for staking.

Journalist

Posted: September 26, 2025

Key Takeaways
Why did FLR’s price surge recently?
The launch of FXRP allowed XRP to be minted as an overcollateralized asset for DeFi use, sparking aggressive buying.

What could impact FLR’s next move?
If buyer demand holds, FLR may retest $0.0278, but strong profit-taking could drive it down to $0.023 support.

 Flare Network [FLR] surged to a 9-month high of $0.0285 before sharply retracing to $0.025 at press time. 

Over the same period, its volume surged 347% to $52 million, while its market cap reached a new high of $2.1 billion, indicating steady capital flow.

But what triggered the price hike?

The recent launch of FXRP primarily drove Flare’s price uptick. According to an official report, Flare launched its FAssets protocol, starting with FXRP v1, a version of XRP designed for DeFi. 

This move aims to allow Ripple [XRP] holders to mint FXRP on Flare and access lending liquidity pools and DEXs on the network.

The rollout marks the first time that XRP, a non-smart contract, can be used in a composable DeFi system without a third party. 

Importantly, the FAssets are designed to convert XRP tokens into one-to-one representations secured through overcollateralized assets and deployed across DeFi protocols. 

Retail buyers jump into the market
Significantly, following the FXRP rollout, buyers jumped into the market to accumulate the altcoin. According to Coinalyze, FLR saw $202 million in Buy Volume compared to $190 million in Sell Volume. 

Source: Coinalyze

As a result, the altcoin saw a positive Buy Sell Delta of 12 million FLR tokens, a clear sign of aggressive spot accumulation. 

Historically, increased accumulation has resulted in an upward pressure, often a prelude to higher prices. 

Profit takers, join the party
As expected, as Flare jumped on its price charts, holders who have been underwater jumped into the market to cash out. 

According to Coinglass, FLR has recorded positive Spot Netflow for ten consecutive days. At press time, Netflow was $222.5k, indicating higher inflows, a clear sign of sustained selling activity. 

Source: CoinGlass

Often, when profit-taking activity holds for a sustained period, it causes downward pressure, resulting in a market pullback. 

Can FLR hold recent gains?
According to AMBCrypto’s analysis, Flare soared as investors rushed into the market to accumulate, driven by the launch of FXRP. 

For that reason, the altcoin’s Stochastic RSI made a bullish crossover, reaching 66.9, indicating strong upward momentum. 

Source: TradingView

Likewise, its Relative Strength Index (RSI) jumped to 69 before retracing to 61, further confirming increased buyer and seller activity. 

Typically, when these momentum indicators edge into bullish territory, they signal trend continuation potential. Thus, if demand witnessed in the past day holds, FLR will reclaim $0.0278 and target $0.0289.

However, profit takers are highly active in the market and pose a significant threat to the uptrend. If sellers overwhelm the market, the correction will continue with $0.023 as a critical support level.

The Shiba Inu developers have issued a new statement about the Shibarium bridge. In it, they openly admit that developers made mistakes in the way the bridge was set up and managed.

A bullish Dogecoin price prediction is back on the table as Thumzup Media, the firm that recently acquired a DOGE mining operation, just announced a $10 million stock buyback.

One mysterious whale has been quietly accumulating PI tokens even as the broader market rushes to dump them – raising the question: what does this buyer know that others don't, and does it point to a bullish Pi Coin price prediction?Despite launching with major hype, Pi (PI) has struggled to live up to expectations, crashing

Terrill Dicki
Sep 25, 2025 22:33

PEPE price prediction shows potential 85% upside to $0.0000162 within 2-4 weeks, but oversold RSI at 35.53 and bearish MACD signal suggest cautious approach needed.

PEPE Price Prediction Summary
• PEPE short-term target (1 week): $0.00000914 (+4.2% from current levels)
• Pepe medium-term forecast (1 month): $0.0000120-$0.0000162 range
• Key level to break for bullish continuation: $0.00000914 resistance
• Critical support if bearish: $0.00000796 must hold

Recent Pepe Price Predictions from Analysts
The latest PEPE price prediction data reveals a compelling bullish consensus among analysts, despite current technical weakness. WalletInvestor's progressive forecasts show an ambitious trajectory, with their most recent Pepe forecast targeting $0.0000162 - representing a potential 85% surge from current price levels.

The prediction timeline shows interesting volatility expectations. Starting from $0.00000351 on September 21st, analysts anticipated steady gains through $0.00000796 and $0.00000914, before projecting a temporary pullback to $0.00000876. However, the September 25th PEPE price target of $0.0000162 suggests analysts expect a significant breakout phase.

This progression indicates analysts view the recent price action as accumulation before a major move, despite the current bearish technical setup showing a -5.50% daily decline.

PEPE Technical Analysis: Setting Up for Contrarian Reversal
Current Pepe technical analysis presents a classic oversold setup that could fuel the predicted recovery. The RSI reading of 35.53 sits in neutral territory but approaches oversold conditions, historically a favorable zone for PEPE reversals.

The MACD histogram showing bearish momentum at -0.0000 appears to be bottoming out, while the Stochastic indicators (%K at 6.25, %D at 7.43) are deeply oversold. This extreme positioning often precedes sharp reversals in meme cryptocurrencies like PEPE.

Most significantly, PEPE's position at 0.0311 relative to Bollinger Bands indicates the price is hugging the lower band - a technical condition that frequently leads to mean reversion toward the middle band. The current "Weak Bullish" overall trend classification suggests underlying strength despite near-term pressure.

Volume analysis shows robust $129.4 million in 24-hour trading on Binance, indicating sustained interest despite the price decline. This volume profile supports the bullish Pepe forecast as it demonstrates institutional and retail participation remains active.

Pepe Price Targets: Bull and Bear Scenarios
Bullish Case for PEPE
The primary PEPE price target of $0.0000162 aligns with historical resistance levels and represents a logical extension of the recent analyst predictions. To reach this target, PEPE must first reclaim $0.00000914, which serves as the immediate resistance barrier.

A successful break above $0.00000914 would likely trigger momentum buying, potentially driving price toward the $0.0000120-$0.0000140 range within 2-3 weeks. The final push to $0.0000162 would require broader meme coin sector strength and could materialize within the 30-day forecast window.

Technical confirmation for this bullish scenario would come from RSI breaking above 50, MACD histogram turning positive, and sustained volume above current levels.

Bearish Risk for Pepe
The primary risk to bullish PEPE price prediction scenarios lies in a breakdown below the critical $0.00000796 support level. This area has provided multiple bounces and represents the foundation of the current consolidation pattern.

A decisive break below $0.00000796 could trigger stops and algorithmic selling, potentially driving PEPE toward $0.00000650-$0.00000700 range. Such a decline would invalidate the near-term bullish Pepe forecast and suggest a deeper correction is underway.

Risk factors include broader crypto market weakness, reduced meme coin speculation, or failure to hold above the lower Bollinger Band for extended periods.

Should You Buy PEPE Now? Entry Strategy
Based on current Pepe technical analysis, a staged entry approach offers the best risk-reward profile. Initial positions could be established at current levels around $0.00000876, representing the predicted pullback level from analyst forecasts.

The optimal buy or sell PEPE decision depends on risk tolerance. Conservative traders should wait for RSI to exceed 40 and MACD to show initial signs of positive divergence. Aggressive traders can accumulate on current weakness, targeting the oversold bounce potential.

Stop-loss placement should be positioned below $0.00000750, representing a 14% maximum loss from current entry levels. This provides adequate cushion while protecting against major breakdown scenarios.

Position sizing should remain modest given PEPE's inherent volatility, with maximum 1-2% portfolio allocation recommended for most investors.

PEPE Price Prediction Conclusion
The PEPE price prediction for the next 30 days carries a MEDIUM-HIGH confidence level, with target range of $0.0000120-$0.0000162 representing 37-85% upside potential. The combination of oversold technical conditions and bullish analyst consensus creates favorable risk-reward dynamics.

Key indicators to monitor for prediction confirmation include RSI breaking above 45, MACD histogram turning positive, and successful reclaim of $0.00000914 resistance. These developments would validate the bullish Pepe forecast timeline.

The prediction timeline suggests initial movement within 7-10 days, with primary targets achievable within 3-4 weeks assuming normal market conditions. Failure to hold $0.00000796 support would invalidate this forecast and require reassessment of the medium-term outlook.

Image source: Shutterstock

pepe price forcast
pepe price prediction